EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

Keywords

Hepatocellular carcinomaMedicineClinical PracticeLiver cancerCancerInternal medicineCause of deathHepatocellular cancerIntensive care medicineOncologyFamily medicineDisease

MeSH Terms

CarcinomaHepatocellularDisease ManagementEuropeGastroenterologyHumansLiver NeoplasmsPractice Guidelines as TopicSocietiesMedical

Affiliated Institutions

Related Publications

Hepatocellular Carcinoma

Augusto Villanueva

Primary liver cancer is the fourth most common tumor worldwide. Hepatocellular carcinoma occurs mainly in the context of cirrhosis, hepatitis B or C virus infection, or nonalcoh...

2019 New England Journal of Medicine 4412 citations

Update on prevention, diagnosis, and treatment of chronic hepatitis B

Norah A. Terrault , Anna S. Lok , Brian J. McMahon +6 more

Potential conflict of interest: Dr. Hwang received grants from Merck and Gilead. Dr. Chang advises Arbutus. Dr. Lok received grants from Gilead and Bristol‐Myers Squibb. Dr. Jon...

2018 Hepatology 4007 citations

Hepatocellular carcinoma

Josep M. Llovet , Robin Kate Kelley , Augusto Villanueva +7 more

Liver cancer remains a global health challenge, with an estimated incidence of >1 million cases by 2025. Hepatocellular carcinoma (HCC) is the most common form of liver cance...

2021 Nature Reviews Disease Primers 5784 citations

Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial

Masatoshi Kudo , Richard S. Finn , Shukui Qin +19 more

In a phase 2 trial, lenvatinib, an inhibitor of VEGF receptors 1-3, FGF receptors 1-4, PDGF receptor α, RET, and KIT, showed activity in hepatocellular carcinoma. We aimed...

2018 The Lancet 5118 citations

Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults

Gregory C. Vernon , Ancha Baranova , Zobair M. Younossi

Aliment Pharmacol Ther 2011; 34: 274–285 Summary Background Non‐alcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease, and its worldwide prevalence co...

2011 Alimentary Pharmacology & Therapeutics 3042 citations

Publication Info

Year: 2018
Type: review
Volume: 69
Issue: 1
Pages: 182-236
Citations: 11069
Access: Closed

External Links

Download PDF (Free) View on DOI.org PubMed Semantic Scholar

Social Impact

Altmetric

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

11069

OpenAlex

124

Influential

6525

CrossRef

Cite This

APA Style

                            
                                
                                    Peter R. Galle, 
                                
                                    Alejandro Forner, 
                                
                                    Josep M. Llovet
                                
                                et al.
                            
                            (2018). 
                            EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. 
                            Journal of Hepatology
                            , 69
                            (1)
                            , 182-236.
                            https://doi.org/10.1016/j.jhep.2018.03.019
                        

Identifiers

DOI: 10.1016/j.jhep.2018.03.019
PMID: 29628281

Data Quality

Data completeness: 68%